Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group
Hino Masayuki, Matsumura Itaru, Nomura Shosaku and 10 more
Journal of Hematology & Oncology · 2011
doi:10.1186/1756-8722-4-14 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Intravascular large B-cell lymphoma (B-IVL) is listed as a distinct disease entity in the World Health Organization(WHO) classification for lymphoid neoplasms [1].The disease is rare, and information for its exact frequency among non-Hodgkin lymphoma (NHL) has been extremely limited.There have been several reports mainly from Asian countries describing the different disease frequencies [2-4].In addition, population of the cases was variously described among these reports.Therefore it is difficult to know the geographical difference in disease frequency, which might be helpful for understanding pathogenesis of disease.From November 1999 to December 2010, a total of 5,085 cases were registered with the Osaka Lymphoma Study Group (OLSG), which was established in 1999, and more than 60 institutes in Osaka area, Japan participate to it.All of the hematoxylin and eosin-and immunoperoxidase-stained sections were reviewed by one of the authors (KA).A diagnosis of malignant lymphoma was confirmed in 4,066 cases (80.0%).Of these 4,066 cases, 3,726 (91.6%) were NHL and 340 (8.4%) Hodgkin lymphoma.Number of cases with DLBCL and B-IVL was 1,815(44.6% of all ML, 48.7% of NHL) and 9(0.22% of all ML, 0.24% of NHL), respectively.Histologic criteria for the diagnosis of B-IVL is selective growth of Blymphoid cells, usually with large size, within lumina of small or intermediated vessels.9 cases of B-IVL in OLSG were summarized in Table 1.The median age of the B-IVL patients (67 years old) at biopsy for diagnosis in the present series was similar to that of the previous reports from Japan and Italy, but slightly older than that from Thailand [4-6].Females
Abstract licence: CC BY-NC-ND
References13
13 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.